Meteor Biotech joins brain organoids consortium
Can food influence gene activity?
Lab-engineered proteins: a promising treatment for liver disease
Insilico Medicine And SK Biopharmaceuticals to collaborate in $2.5bn deal
UCB picks Rowen as $2bn manufacturing campus
Researchers move closer to preventing pandemics
Copper overload kills cancer cells
Lyme disease vaccine shows strong efficacy in phase 3 trial
FDA approves pill for plaque psoriasis
Crossbow Therapeutics raises $77m to treat cancer
Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space
Excalipoint Therapeutics launches with $68.7m to develop T-Cell engager therapies